GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for synaptic vesicle glycoprotein 2B (Q7L1I2)

Analyse AlphaFold monomer V2.0 prediction for synaptic vesicle glycoprotein 2B (Q7L1I2) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q7L1I2
Type
protein
Length
683 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x6Ed09D80e98fE15DE51C9E7a8896AbF1f2365C3e
Molecule
Synaptic vesicle glycoprotein 2B
UniProt
Q7L1I2
Pockets
7 · best druggability 0.76

Structure

1 distinct chain · 61% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASynaptic vesicle glycoprotein 2Bprotein68361% helix, 9% strandQ7L1I2

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15730.760.8364empty
2550.720.9918empty
34940.640.7654empty
41240.470.7923empty
5950.400.7720empty

Compared structures

  • 8UO8 · Structure of synaptic vesicle protein 2B with padsevonil · an experimental structure of the same protein · chain A against A, TM-score 0.79

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.